Brigham and Women's Hospital Researchers Discover Blood Biomarker for Lou Gehrig's Disease, Could Lead to New Treatments

8/7/2012 7:50:57 AM

Researchers from Brigham and Women's Hospital (BWH) are the first to discover that changes in monocytes (a type of white blood cell) are a biomarker for amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease. This finding also brings the medical community a step closer toward a new treatment for the debilitating neurological disease that affects approximately 30,000 Americans.

Read at ScienceDaily

Read at Red Orbit

Read at Fox News

Read at MedicalXpress

Read Article at

Related Companies

News Categories

• ScienceDaily

• Red Orbit

• Fox News

• MedicalXpress

• Brigham and Women's Hospital